106
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Liposomal delivery of α-Interferon to murine bladder tumor cells via transferrin receptor-mediated endocytosis

, , , , , & show all
Pages 111-118 | Received 05 Aug 1997, Accepted 30 Sep 1997, Published online: 02 Jul 2009

References

  • Aguet M., Blanchard B. High-affinity binding of 125I-labeled mouse interferon to a specific cell surface receptor. Nature 1980; 284: 459–461
  • Bangham A. D., Standish M. M., Watkins J. C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mal. Biol. 1965; 13: 238–252
  • Borden E. C., Groveman D. S., Nasu T., Reznikoff C., Bryan G. T. Antiproliferative activities of interferons against human bladder carcinoma cell lines in vitro. J. Ural. 1984; 132: 800–803
  • Faulk W. P., Hsi B. L., Stevens P. J. Transferrin and transferrin receptors in carcinoma of breast. Lancet 1980; 2: 390–392
  • Frangos D. N., Killion J. J., Fan D., Fishbeck R, Eschenbach A. C., Fidler I. J. The development of liposomes containing interferon-a for the intravesical therapy of human superficial bladder cancer. J. Ural. 1990; 143: 1252–1256
  • Glashan R. W. A randomized controlled study of intravesical a-2b-interferon in carcinoma in situ of the bladder. J. Urol. 1990; 144: 658–661
  • Harrison G. S. M., Green D. F., Neuling D. W. W., Richards B., Robison M. R. G., Smith P. H. A phase II study of intravesical mitomycin C in the treatment of superficial bladder cancer. Br. J. Urol. 1983; 55: 676–679
  • Hoeltl W., Hasun R., Albrecht W., Marbergger M. How effective is topical α-2b interferon in preventing recurrence of superficial bladder cancer?. Br. J. Urol. 1991; 68: 495–498
  • Jones M. N. The surface properties of phospholipid liposome systems and their characterization. Adv. Colloid Interface Sci. 1995; 54: 93–128
  • Kalble T., Beer M., Staehler G. Intravesical prophylaxis with BCG versus interferon-a for superficial bladder cancer. J. Urol. 1994; 150: 232A
  • Killion J. J., Fan D., Bucana C. D., Frangos D. N., Price J. E., Fidler I. J. Augmentation of antiproliferative activity of interferon-a against human bladder tumor cell lines by encapsulation of interferon-a within liposomes. J. Natl. Cancer Inst. 1989; 81: 1387–1392
  • Killion J. J., Fishbeck R., Bar-Eli M., Chernajovsky Y. Delivery of interferon to intracellular pathways by encapsulation into multilamellar liposomes is independent of the status of interferon receptors. Cytokine 1994; 6: 443–449
  • Kumar R., Atlas I. Interferon-α induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: Role in growth regulation. Proc. Natl. Acad. Sci. USA 1992; 89: 6599–6603
  • Kuroki T., Takeda T., Nishiguchi S., Otani S., Kobayashi K. Inhibition of intracellular putrescine by interferons to suppress growth of human hepatoma cells. Pax. Am. Assoc. Cancer Res. 1993; 34: A236
  • Lamm D. L., Riggs D. R., Traynelis C. L., Nseyo U. O. Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder. J. Ural. 1995; 153: 1444–1450
  • Lattime E. C., Gomella L. G., McCue P. A. Murine bladder carcinoma cells present antigen to BCG-specific CD4+ T cells. Cancer Res. 1992; 52: 4286–4290
  • Mogensen K. E., Bandu M. T. Kinetic evidence for an activation step following binding of human interferon-α to the membrane receptors of Daudi cells. Eur. J. Biochem. 1983; 134: 355–364
  • Parker S. L., Tong T., Bolden S., Wingo P. A. Cancer statistics. Cα-A Cancer J. Clinicians 1997; 47: 5–27
  • Torti F. M., Shortlffe L. D., Williams R. D., Pitts W. C., Kempson R. L., Ross J. C., Palmer J., Meyers F., Ferrari M., Hannigan J., Spiegel R., Mcwriter K., Freiha F. Alpha-interferon in superficial bladder cancer: A northern California oncology group study. J. Clin. Oncol. 1988; 6: 476–483
  • Tovey M. G., Dron M., Mogensen K. E., Lebleu B., Mechti N., Bego-Lours-Guymarho J. Isolation of Daudi cells with reduced sensitivity to interferon. II. On the mechanisms of resistance. J. Genet. Virol. 1983; 64: 2649–2653
  • Verhaegen M., Divizia M., Vandenbussche P., Kuwata T., Content J. Abnormal behavior of interferon-induced enzymatic activities in an interferon-resistant cell line. Proc. Natl. Acad. Sci. USA 1980; 77: 4479–4483
  • Zincke H., Utz D. C., Taylor W. F., Meyers R. P., Leary F. J. Influence of thiotepa doxorubicin instillation at time of transurethral surgical treatment of bladder cancer on tumor recurrence: A prospective, randomized, double blind, controlled trial. J. Urol. 1983; 129: 505–509

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.